
### [MONDO:0000592](http://purl.obolibrary.org/obo/MONDO_0000592)
**Label:** specific developmental disorder

**Subclasses:** [MONDO:0000815](http://purl.obolibrary.org/obo/MONDO_0000815) (fetal nicotine spectrum disorder), [MONDO:0012484](http://purl.obolibrary.org/obo/MONDO_0012484) (prosopagnosia, hereditary), [MONDO:0000495](http://purl.obolibrary.org/obo/MONDO_0000495) (oppositional defiant disorder (disease)), [MONDO:0005302](http://purl.obolibrary.org/obo/MONDO_0005302) (attention deficit hyperactivity disorder), [MONDO:0004730](http://purl.obolibrary.org/obo/MONDO_0004730) (speech disorder), [MONDO:0011710](http://purl.obolibrary.org/obo/MONDO_0011710) (SLI1), [MONDO:0010348](http://purl.obolibrary.org/obo/MONDO_0010348) (DYX9), [MONDO:0011711](http://purl.obolibrary.org/obo/MONDO_0011711) (SLI2), [MONDO:0012232](http://purl.obolibrary.org/obo/MONDO_0012232) (STUT2), [MONDO:0011780](http://purl.obolibrary.org/obo/MONDO_0011780) (SLI3), [MONDO:0000667](http://purl.obolibrary.org/obo/MONDO_0000667) (auditory agnosia), [MONDO:0000668](http://purl.obolibrary.org/obo/MONDO_0000668) (autotopagnosia), [MONDO:0000669](http://purl.obolibrary.org/obo/MONDO_0000669) (color agnosia), [MONDO:0000663](http://purl.obolibrary.org/obo/MONDO_0000663) (anosognosia), [MONDO:0000664](http://purl.obolibrary.org/obo/MONDO_0000664) (apperceptive agnosia), [MONDO:0000665](http://purl.obolibrary.org/obo/MONDO_0000665) (apraxia), [MONDO:0000666](http://purl.obolibrary.org/obo/MONDO_0000666) (associative agnosia), [MONDO:0012917](http://purl.obolibrary.org/obo/MONDO_0012917) (SLI4), [MONDO:0006800](http://purl.obolibrary.org/obo/MONDO_0006800) (ideomotor apraxia), [MONDO:0006766](http://purl.obolibrary.org/obo/MONDO_0006766) (gait apraxia), [MONDO:0000660](http://purl.obolibrary.org/obo/MONDO_0000660) (akinetopsia), [MONDO:0000661](http://purl.obolibrary.org/obo/MONDO_0000661) (alexithymia), [MONDO:0000662](http://purl.obolibrary.org/obo/MONDO_0000662) (amusia), [MONDO:0001074](http://purl.obolibrary.org/obo/MONDO_0001074) (chronic tic disorder), [MONDO:0013841](http://purl.obolibrary.org/obo/MONDO_0013841) (STUT3), [MONDO:0013844](http://purl.obolibrary.org/obo/MONDO_0013844) (STUT4), [MONDO:0012461](http://purl.obolibrary.org/obo/MONDO_0012461) (bulimia nervosa, susceptibility to, 2), [MONDO:0008483](http://purl.obolibrary.org/obo/MONDO_0008483) (STUT1), [MONDO:0002419](http://purl.obolibrary.org/obo/MONDO_0002419) (transient tic disorder), [MONDO:0003227](http://purl.obolibrary.org/obo/MONDO_0003227) (prosopagnosia (disease)), [MONDO:0000598](http://purl.obolibrary.org/obo/MONDO_0000598) (aphasia), [MONDO:0000599](http://purl.obolibrary.org/obo/MONDO_0000599) (writing disorder), [MONDO:0001568](http://purl.obolibrary.org/obo/MONDO_0001568) (mixed receptive-expressive language disorder), [MONDO:0001441](http://purl.obolibrary.org/obo/MONDO_0001441) (pica disease), [MONDO:0011418](http://purl.obolibrary.org/obo/MONDO_0011418) (DYX3), [MONDO:0005489](http://purl.obolibrary.org/obo/MONDO_0005489) (dyslexia (disease)), [MONDO:0007661](http://purl.obolibrary.org/obo/MONDO_0007661) (Tourette syndrome), [MONDO:0012863](http://purl.obolibrary.org/obo/MONDO_0012863) (attention deficit-hyperactivity disorder, susceptibility to, 6), [MONDO:0012862](http://purl.obolibrary.org/obo/MONDO_0012862) (attention deficit-hyperactivity disorder, susceptibility to, 5), [MONDO:0010843](http://purl.obolibrary.org/obo/MONDO_0010843) (DYX2), [MONDO:0000408](http://purl.obolibrary.org/obo/MONDO_0000408) (fetal alcohol spectrum disorder), [MONDO:0016011](http://purl.obolibrary.org/obo/MONDO_0016011) (fetal alcohol syndrome), [MONDO:0001697](http://purl.obolibrary.org/obo/MONDO_0001697) (reading disorder), [MONDO:0002420](http://purl.obolibrary.org/obo/MONDO_0002420) (tic disorder), [MONDO:0002265](http://purl.obolibrary.org/obo/MONDO_0002265) (stereotypic movement disorder), [MONDO:0004681](http://purl.obolibrary.org/obo/MONDO_0004681) (learning disability), [MONDO:0012168](http://purl.obolibrary.org/obo/MONDO_0012168) (DYX8), [MONDO:0014184](http://purl.obolibrary.org/obo/MONDO_0014184) (language impairment (disease)), [MONDO:0001301](http://purl.obolibrary.org/obo/MONDO_0001301) (rumination disorder), [MONDO:0007487](http://purl.obolibrary.org/obo/MONDO_0007487) (dyslexia, susceptibility to, 1), [MONDO:0005582](http://purl.obolibrary.org/obo/MONDO_0005582) (binge eating), [MONDO:0012152](http://purl.obolibrary.org/obo/MONDO_0012152) (attention deficit-hyperactivity disorder, susceptibility to, 4), [MONDO:0012151](http://purl.obolibrary.org/obo/MONDO_0012151) (attention deficit-hyperactivity disorder, susceptibility to, 3), [MONDO:0012150](http://purl.obolibrary.org/obo/MONDO_0012150) (attention deficit-hyperactivity disorder, susceptibility to, 2), [MONDO:0001712](http://purl.obolibrary.org/obo/MONDO_0001712) (alexia), [MONDO:0005638](http://purl.obolibrary.org/obo/MONDO_0005638) (agnosia), [MONDO:0001276](http://purl.obolibrary.org/obo/MONDO_0001276) (expressive language disorder), [MONDO:0001552](http://purl.obolibrary.org/obo/MONDO_0001552) (dyscalculia (disease)), [MONDO:0005352](http://purl.obolibrary.org/obo/MONDO_0005352) (conduct disorder), [MONDO:0005351](http://purl.obolibrary.org/obo/MONDO_0005351) (anorexia nervosa), [MONDO:0011747](http://purl.obolibrary.org/obo/MONDO_0011747) (DYX5), [MONDO:0000716](http://purl.obolibrary.org/obo/MONDO_0000716) (agraphia), [MONDO:0013076](http://purl.obolibrary.org/obo/MONDO_0013076) (attention deficit-hyperactivity disorder, susceptibility to, 7), [MONDO:0000678](http://purl.obolibrary.org/obo/MONDO_0000678) (simultanagnosia), [MONDO:0000679](http://purl.obolibrary.org/obo/MONDO_0000679) (social emotional agnosia), [MONDO:0000674](http://purl.obolibrary.org/obo/MONDO_0000674) (mirror agnosia), [MONDO:0000675](http://purl.obolibrary.org/obo/MONDO_0000675) (pain agnosia), [MONDO:0000676](http://purl.obolibrary.org/obo/MONDO_0000676) (phonagnosia), [MONDO:0000677](http://purl.obolibrary.org/obo/MONDO_0000677) (semantic agnosia), [MONDO:0000670](http://purl.obolibrary.org/obo/MONDO_0000670) (cortical deafness), [MONDO:0000395](http://purl.obolibrary.org/obo/MONDO_0000395) (alcohol-related birth defect), [MONDO:0000671](http://purl.obolibrary.org/obo/MONDO_0000671) (finger agnosia (disease)), [MONDO:0000672](http://purl.obolibrary.org/obo/MONDO_0000672) (form agnosia), [MONDO:0007743](http://purl.obolibrary.org/obo/MONDO_0007743) (attention deficit-hyperactivity disorder), [MONDO:0000673](http://purl.obolibrary.org/obo/MONDO_0000673) (integrative agnosia), [MONDO:0004750](http://purl.obolibrary.org/obo/MONDO_0004750) (language disorder), [MONDO:0000393](http://purl.obolibrary.org/obo/MONDO_0000393) (partial fetal alcohol syndrome), [MONDO:0012149](http://purl.obolibrary.org/obo/MONDO_0012149) (attention deficit-hyperactivity disorder, susceptibility to, 1), [MONDO:0002905](http://purl.obolibrary.org/obo/MONDO_0002905) (mutism (disease)), [MONDO:0002904](http://purl.obolibrary.org/obo/MONDO_0002904) (echolalia (disease)), [MONDO:0000723](http://purl.obolibrary.org/obo/MONDO_0000723) (stutter disorder), [MONDO:0002903](http://purl.obolibrary.org/obo/MONDO_0002903) (articulation disorder), [MONDO:0000724](http://purl.obolibrary.org/obo/MONDO_0000724) (specific language impairment), [MONDO:0000685](http://purl.obolibrary.org/obo/MONDO_0000685) (visual agnosia (disease)), [MONDO:0004922](http://purl.obolibrary.org/obo/MONDO_0004922) (developmental coordination disorder), [MONDO:0000686](http://purl.obolibrary.org/obo/MONDO_0000686) (visual verbal agnosia), [MONDO:0003039](http://purl.obolibrary.org/obo/MONDO_0003039) (nominal aphasia), [MONDO:0000681](http://purl.obolibrary.org/obo/MONDO_0000681) (tactile agnosia), [MONDO:0000682](http://purl.obolibrary.org/obo/MONDO_0000682) (time agnosia), [MONDO:0000683](http://purl.obolibrary.org/obo/MONDO_0000683) (topographical agnosia), [MONDO:0003038](http://purl.obolibrary.org/obo/MONDO_0003038) (dysgraphia (disease)), [MONDO:0000684](http://purl.obolibrary.org/obo/MONDO_0000684) (verbal auditory agnosia), [MONDO:0005451](http://purl.obolibrary.org/obo/MONDO_0005451) (eating disorder), [MONDO:0000680](http://purl.obolibrary.org/obo/MONDO_0000680) (astereognosia (disease)), [MONDO:0005452](http://purl.obolibrary.org/obo/MONDO_0005452) (bulimia nervosa), [MONDO:0002182](http://purl.obolibrary.org/obo/MONDO_0002182) (communication disorder), [MONDO:0011846](http://purl.obolibrary.org/obo/MONDO_0011846) (bulimia nervosa, susceptibility to, 1), [MONDO:0011689](http://purl.obolibrary.org/obo/MONDO_0011689) (DYX6), 

**Mapped go classes:** [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0007412](http://purl.obolibrary.org/obo/GO_0007412) (axon target recognition), [GO:0021675](http://purl.obolibrary.org/obo/GO_0021675) (nerve development), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0097484](http://purl.obolibrary.org/obo/GO_0097484) (dendrite extension), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0007406](http://purl.obolibrary.org/obo/GO_0007406) (negative regulation of neuroblast proliferation), [GO:0043195](http://purl.obolibrary.org/obo/GO_0043195) (terminal bouton), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0007409](http://purl.obolibrary.org/obo/GO_0007409) (axonogenesis), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0033138](http://purl.obolibrary.org/obo/GO_0033138) (positive regulation of peptidyl-serine phosphorylation), [GO:0042427](http://purl.obolibrary.org/obo/GO_0042427) (serotonin biosynthetic process), [GO:0060079](http://purl.obolibrary.org/obo/GO_0060079) (excitatory postsynaptic potential), [GO:0030141](http://purl.obolibrary.org/obo/GO_0030141) (secretory granule), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0007268](http://purl.obolibrary.org/obo/GO_0007268) (chemical synaptic transmission), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0003341](http://purl.obolibrary.org/obo/GO_0003341) (cilium movement), [GO:0004398](http://purl.obolibrary.org/obo/GO_0004398) (histidine decarboxylase activity), [GO:0042423](http://purl.obolibrary.org/obo/GO_0042423) (catecholamine biosynthetic process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0007416](http://purl.obolibrary.org/obo/GO_0007416) (synapse assembly), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:1990138](http://purl.obolibrary.org/obo/GO_1990138) (neuron projection extension), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0060080](http://purl.obolibrary.org/obo/GO_0060080) (inhibitory postsynaptic potential), [GO:0019752](http://purl.obolibrary.org/obo/GO_0019752) (carboxylic acid metabolic process), [GO:0030534](http://purl.obolibrary.org/obo/GO_0030534) (adult behavior), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0014047](http://purl.obolibrary.org/obo/GO_0014047) (glutamate secretion), [GO:0007195](http://purl.obolibrary.org/obo/GO_0007195) (adenylate cyclase-inhibiting dopamine receptor signaling pathway), [GO:0048812](http://purl.obolibrary.org/obo/GO_0048812) (neuron projection morphogenesis), [GO:0060548](http://purl.obolibrary.org/obo/GO_0060548) (negative regulation of cell death), [GO:0045666](http://purl.obolibrary.org/obo/GO_0045666) (positive regulation of neuron differentiation), [GO:0007631](http://purl.obolibrary.org/obo/GO_0007631) (feeding behavior), [GO:0045664](http://purl.obolibrary.org/obo/GO_0045664) (regulation of neuron differentiation), [GO:0043523](http://purl.obolibrary.org/obo/GO_0043523) (regulation of neuron apoptotic process), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0009416](http://purl.obolibrary.org/obo/GO_0009416) (response to light stimulus), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:0016192](http://purl.obolibrary.org/obo/GO_0016192) (vesicle-mediated transport), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0019222](http://purl.obolibrary.org/obo/GO_0019222) (regulation of metabolic process), [GO:0016597](http://purl.obolibrary.org/obo/GO_0016597) (amino acid binding), [GO:0030124](http://purl.obolibrary.org/obo/GO_0030124) (AP-4 adaptor complex), [GO:0070986](http://purl.obolibrary.org/obo/GO_0070986) (left/right axis specification), [GO:0016358](http://purl.obolibrary.org/obo/GO_0016358) (dendrite development), [GO:0048668](http://purl.obolibrary.org/obo/GO_0048668) (collateral sprouting), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0004497](http://purl.obolibrary.org/obo/GO_0004497) (monooxygenase activity), [GO:0007368](http://purl.obolibrary.org/obo/GO_0007368) (determination of left/right symmetry), [GO:0021520](http://purl.obolibrary.org/obo/GO_0021520) (spinal cord motor neuron cell fate specification), [GO:0001662](http://purl.obolibrary.org/obo/GO_0001662) (behavioral fear response), [GO:0048672](http://purl.obolibrary.org/obo/GO_0048672) (positive regulation of collateral sprouting), [GO:0030117](http://purl.obolibrary.org/obo/GO_0030117) (membrane coat), [GO:0048670](http://purl.obolibrary.org/obo/GO_0048670) (regulation of collateral sprouting), [GO:0030516](http://purl.obolibrary.org/obo/GO_0030516) (regulation of axon extension), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0006547](http://purl.obolibrary.org/obo/GO_0006547) (histidine metabolic process), [GO:0006548](http://purl.obolibrary.org/obo/GO_0006548) (histidine catabolic process), [GO:0048675](http://purl.obolibrary.org/obo/GO_0048675) (axon extension), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0071542](http://purl.obolibrary.org/obo/GO_0071542) (dopaminergic neuron differentiation), [GO:0001657](http://purl.obolibrary.org/obo/GO_0001657) (ureteric bud development), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0061193](http://purl.obolibrary.org/obo/GO_0061193) (taste bud development), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0060287](http://purl.obolibrary.org/obo/GO_0060287) (epithelial cilium movement involved in determination of left/right asymmetry), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0061136](http://purl.obolibrary.org/obo/GO_0061136) (regulation of proteasomal protein catabolic process), [GO:0009072](http://purl.obolibrary.org/obo/GO_0009072) (aromatic amino acid family metabolic process), [GO:0006120](http://purl.obolibrary.org/obo/GO_0006120) (mitochondrial electron transport, NADH to ubiquinone), [GO:0016607](http://purl.obolibrary.org/obo/GO_0016607) (nuclear speck), [GO:0008021](http://purl.obolibrary.org/obo/GO_0008021) (synaptic vesicle), [GO:0007212](http://purl.obolibrary.org/obo/GO_0007212) (dopamine receptor signaling pathway), [GO:0006520](http://purl.obolibrary.org/obo/GO_0006520) (cellular amino acid metabolic process), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0021514](http://purl.obolibrary.org/obo/GO_0021514) (ventral spinal cord interneuron differentiation), [GO:0007612](http://purl.obolibrary.org/obo/GO_0007612) (learning), [GO:0006886](http://purl.obolibrary.org/obo/GO_0006886) (intracellular protein transport), [GO:0045843](http://purl.obolibrary.org/obo/GO_0045843) (negative regulation of striated muscle tissue development), [GO:0007214](http://purl.obolibrary.org/obo/GO_0007214) (gamma-aminobutyric acid signaling pathway), [GO:0007611](http://purl.obolibrary.org/obo/GO_0007611) (learning or memory), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0048169](http://purl.obolibrary.org/obo/GO_0048169) (regulation of long-term neuronal synaptic plasticity), [GO:0048167](http://purl.obolibrary.org/obo/GO_0048167) (regulation of synaptic plasticity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0051965](http://purl.obolibrary.org/obo/GO_0051965) (positive regulation of synapse assembly), [GO:2000171](http://purl.obolibrary.org/obo/GO_2000171) (negative regulation of dendrite development), [GO:0016714](http://purl.obolibrary.org/obo/GO_0016714) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen), [GO:0060271](http://purl.obolibrary.org/obo/GO_0060271) (cilium assembly), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0030061](http://purl.obolibrary.org/obo/GO_0030061) (mitochondrial crista), [GO:0008038](http://purl.obolibrary.org/obo/GO_0008038) (neuron recognition), [GO:0099083](http://purl.obolibrary.org/obo/GO_0099083) (retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission), [GO:0007623](http://purl.obolibrary.org/obo/GO_0007623) (circadian rhythm), [GO:0005169](http://purl.obolibrary.org/obo/GO_0005169) (neurotrophin TRKB receptor binding), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0046668](http://purl.obolibrary.org/obo/GO_0046668) (regulation of retinal cell programmed cell death), [GO:0004510](http://purl.obolibrary.org/obo/GO_0004510) (tryptophan 5-monooxygenase activity), [GO:0097730](http://purl.obolibrary.org/obo/GO_0097730) (non-motile cilium), [GO:0042592](http://purl.obolibrary.org/obo/GO_0042592) (homeostatic process), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0030331](http://purl.obolibrary.org/obo/GO_0030331) (estrogen receptor binding), [GO:0036159](http://purl.obolibrary.org/obo/GO_0036159) (inner dynein arm assembly), [GO:0048172](http://purl.obolibrary.org/obo/GO_0048172) (regulation of short-term neuronal synaptic plasticity), [GO:2000324](http://purl.obolibrary.org/obo/GO_2000324) (positive regulation of glucocorticoid receptor signaling pathway), [GO:0048170](http://purl.obolibrary.org/obo/GO_0048170) (positive regulation of long-term neuronal synaptic plasticity), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0030170](http://purl.obolibrary.org/obo/GO_0030170) (pyridoxal phosphate binding), [GO:0036158](http://purl.obolibrary.org/obo/GO_0036158) (outer dynein arm assembly), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0042596](http://purl.obolibrary.org/obo/GO_0042596) (fear response), [GO:0045861](http://purl.obolibrary.org/obo/GO_0045861) (negative regulation of proteolysis), [GO:0003351](http://purl.obolibrary.org/obo/GO_0003351) (epithelial cilium movement), [GO:0043204](http://purl.obolibrary.org/obo/GO_0043204) (perikaryon), [GO:0001692](http://purl.obolibrary.org/obo/GO_0001692) (histamine metabolic process), [GO:0001694](http://purl.obolibrary.org/obo/GO_0001694) (histamine biosynthetic process), [GO:0006587](http://purl.obolibrary.org/obo/GO_0006587) (serotonin biosynthetic process from tryptophan), [GO:0004952](http://purl.obolibrary.org/obo/GO_0004952) (dopamine neurotransmitter receptor activity), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0032229](http://purl.obolibrary.org/obo/GO_0032229) (negative regulation of synaptic transmission, GABAergic), [GO:0005802](http://purl.obolibrary.org/obo/GO_0005802) (trans-Golgi network), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:0050772](http://purl.obolibrary.org/obo/GO_0050772) (positive regulation of axonogenesis), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0033555](http://purl.obolibrary.org/obo/GO_0033555) (multicellular organismal response to stress), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0031099](http://purl.obolibrary.org/obo/GO_0031099) (regeneration), [GO:0010832](http://purl.obolibrary.org/obo/GO_0010832) (negative regulation of myotube differentiation), [GO:0016831](http://purl.obolibrary.org/obo/GO_0016831) (carboxy-lyase activity), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:1900122](http://purl.obolibrary.org/obo/GO_1900122) (positive regulation of receptor binding), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:1901215](http://purl.obolibrary.org/obo/GO_1901215) (negative regulation of neuron death), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0005813](http://purl.obolibrary.org/obo/GO_0005813) (centrosome), [GO:0042490](http://purl.obolibrary.org/obo/GO_0042490) (mechanoreceptor differentiation), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0033146](http://purl.obolibrary.org/obo/GO_0033146) (regulation of intracellular estrogen receptor signaling pathway), [GO:0071229](http://purl.obolibrary.org/obo/GO_0071229) (cellular response to acid chemical), 

**Class expressions from DL-Learner:**

- Thing 54.04%
- [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion) 51.25%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 36.66%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) 36.61%
- [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) and [GO:0070161](http://purl.obolibrary.org/obo/GO_0070161) (anchoring junction) 36.61%
- [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction) and [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) 36.61%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005208](http://purl.obolibrary.org/obo/GO_0005208) (obsolete amyloid protein) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005207](http://purl.obolibrary.org/obo/GO_0005207) (obsolete extracellular matrix glycoprotein) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005206](http://purl.obolibrary.org/obo/GO_0005206) (obsolete heparin sulfate proteoglycan) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005205](http://purl.obolibrary.org/obo/GO_0005205) (obsolete chondroitin sulfate/dermatan sulfate proteoglycan) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005204](http://purl.obolibrary.org/obo/GO_0005204) (obsolete chondroitin sulfate proteoglycan) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005203](http://purl.obolibrary.org/obo/GO_0005203) (obsolete proteoglycan) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005202](http://purl.obolibrary.org/obo/GO_0005202) (obsolete collagen) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005194](http://purl.obolibrary.org/obo/GO_0005194) (obsolete cell adhesion molecule activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005193](http://purl.obolibrary.org/obo/GO_0005193) (obsolete major urinary protein) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%


